This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CME Cut to 'Sell' at Goldman

Stocks in this article: CME NYX

NEW YORK ( TheStreet) -- CME Group (CME) shares opened slightly lower Monday after Goldman Sachs analysts reduced their recommendation to "Sell" from "Neutral," arguing weak trading volumes will drive analyst profit estimates lower.

"Although we view CME as the leading global futures exchange, with resilient margins and a powerful capital deployment strategy, we believe the Street is too optimistic on CME's near-term EPS outlook (we are 8% below consensus for 2013) given the most recent volume and open interest trends," states the report, from analysts Alexander Blostein and Christopher Johnson.

CME shares have risen 44% on a 12 month forward price-to-earnings ratio since February, when the company said it would increase its dividend target from 35 percent to 50 percent of the previous year's cash earnings. CME said last week it would accelerate next year's dividend payment to this year in order to spare investors an expected higher tax rate in 2013.

Following those announcements, however, Goldman's analysts "expect investor focus could shift back to the firm's core fundamentals, which continue to deteriorate," they write, noting that the amount of open derivatives contracts is down 12% through 11 months of 2012 versus the same time period in 2011.

CME should see "muted volume growth of 2%" in 2013 versus 2012, according to Goldman's analysts. They a potential slowdown in trading of the company's interest rate products due in part to upcoming regulatory changes, market share losses in energy futures, and weaker equity futures activity due to the "potential spillover effect from structural challenges in cash equities."

Goldman's analysts also contend the opportunity to CME from increased exchange trading of over-the-counter derivatives, a key measure of the 2010 Dodd Frank financial reform legislation will not have a significant near-term earnings impact.

Instead of CME, Goldman's analysts argue NYSE Group (NYX) is a better investment due to cost-cutting measures and new buyback authorization, the report states.

-- Written by Dan Freed in New York.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs